On Thursday, the UK Medicines and Healthcare Products Regulatory Agency said Merk and Ridgeback Biotherapeutics’ oral antiviral, molnupiravir, for the treatment of mild-to-moderate Covid-19 …
Tag:
On Thursday, the UK Medicines and Healthcare Products Regulatory Agency said Merk and Ridgeback Biotherapeutics’ oral antiviral, molnupiravir, for the treatment of mild-to-moderate Covid-19 …